Phenomenex and ChromaDex® to Collaborate on Reference Standards Solutions for Dietary Supplements

New Solutions to be Presented at Association of Analytical Communities (AOAC) Annual Meeting Next Week

Torrance, CA and Irvine, CA (September 27, 2012) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, and ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today a collaboration agreement that will provide solutions to customers  with a combination of  reference standards, scientifically valid methods and application support. The collaboration combines Phenomenex's strengths in analytical HPLC (high-performance liquid chromatography) with ChromaDex's extensive line of reference standards, which are used for quality control in dietary supplement manufacturing. The first three new solutions will be presented as scientific posters at the AOAC (Association of Analytical Communities) annual meeting in Las Vegas next week and will be available as technical notes, the first of which can be viewed atwww.phenomenex.com/cdpr.

The FDA has increased its scrutiny of the supplement industry in recent years, precipitating a need for faster, more advanced quality control methods. "The ability to provide a complete package of reference standards and scientifically valid methods strengthens our leadership position and provides a 'one stop shop' for our customers," said Frank Jaksch, CEO and founder of ChromaDex. "The collaboration will deliver tools to help customers meet FDA guidance on cGMP (current good manufacturing practices) for dietary supplements."

Phenomenex maintains a full-service analytical support laboratory, staffed with application scientists who specialize in method development and customized solutions. This team will optimize methods for ChromaDex reference standards, based on the most advanced chromatography technology. This includes working with a variety of sample matrices and will in many cases include the use of Phenomenex's core-shell particle technology and Kinetex® columns.

"This collaboration is consistent with our strategy of providing the most complete solutions to the customers we serve," explains Sky Countryman, manager of PhenoLogix and applied technology for Phenomenex. "We look forward to expanding our involvement with the growing dietary supplement market."

About ChromaDex:
ChromaDex, Inc. is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. ChromaDex's pipeline of proprietary products include patented pTeroPure® pterostilbene, which was named the 2010 North American Most Promising Ingredient of the Year by the independent research company Frost & Sullivan. The company has also launched ProC3G , a natural black rice extract containing 40% cyanidin-3-glucoside and is in the process of developing Nicotinamide Riboside, a novel next-generation B-vitamin. All products are backed with extensive scientific research and intellectual property. For more information about pTeroPure, visit www.pteropure.com or call 949-600-9694

Phenomenex, celebrating its 30th anniversary in 2012, is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.  For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.

Contacts for the Media:  
Jennifer Dahlgren, Dahlgren Communications
Phone: (530) 265-0538
E-mail: [email protected]

Karen Anspach, Phenomenex, Inc.
Phone: (310) 212-0555 Ext. 2243
E-mail: [email protected]

ChromaDex Investor Contact:
The Del Mar Consulting Group, Inc.
Robert B. Prag, President
[email protected]

ChromaDex Contact:
Laura Carney, Executive Assistant
949-419-0288
[email protected]  

Please note new address: